Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
85 participants
INTERVENTIONAL
2015-12-31
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the current study, we will investigate the progression of PTSD symptoms and emotional stress before, during and after therapy. After a semi-structured interview all participants will be asked to report in monthly telephone interviews their core symptoms. Structured interviews after 6 and 12 months are used to validate the outcome. A convenience sample of individuals with a PTSD will be offered participation in the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Change of Neural Network Indicators Through Narrative Treatment of PTSD in Torture Victims
NCT00563888
Immunological Changes Through Narrative Treatment of Post-Traumatic Stress Disorder (PTSD) in Torture Victims
NCT01206790
Treatment Effects of Narrative Exposure Therapy
NCT00660439
Narrative Exposure Therapy (NET)
NCT03777553
Narrative Exposure Therapy in Women With Borderline Personality Disorder and Posttraumatic Stress Disorder
NCT02517723
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Irrespective of treatment and diagnosis, respondents are asked to participate in monthly telephone interviews assessing trauma-related and emotional distress and changes in life. Interviews assessing PTSD, depression symptoms and emotional distress will be conducted 6 and 12 months after the initial interview.
In addition, participants receiving NET will rate their PTSD symptoms and functionality prior to each therapy session.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Narrative Exposure Therapy
Participants with a PTSD diagnosis
Narrative Exposure Therapy
8 - 15 sessions: 1 lifeline session, 5 - 12 sessions narrative exposure, 1-2 sessions of future-oriented counselling
no / standard treatment
Participants with a PTSD diagnosis / other mental health problems / no mental health problems
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Narrative Exposure Therapy
8 - 15 sessions: 1 lifeline session, 5 - 12 sessions narrative exposure, 1-2 sessions of future-oriented counselling
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For non-treatment group: none
Exclusion Criteria
* Cerebro-organic disease
* Acute drug or alcohol intoxication
* Already receiving another psychotherapy
* Anti-epileptic drugs at baseline
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Konstanz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Thomas Elbert
Professor for Clinical Psychology and Behavioural Neuroscience
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Elbert, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
University of Konstanz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Konstanz
Konstanz, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kaltenbach E, Hermenau K, Schauer M, Dohrmann K, Elbert T, Schalinski I. Trajectories of posttraumatic stress symptoms during and after Narrative Exposure Therapy (NET) in refugees. BMC Psychiatry. 2020 Jun 17;20(1):312. doi: 10.1186/s12888-020-02720-y.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ERC-2012-AdG 323977 NET-Course
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.